Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma

Clinical trial NCT04940299 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04940299
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clinical Stage III Cutaneous Melanoma AJCC v8 Clinical Stage IV Cutaneous Melanoma AJCC v8 Locally Advanced Bladder Carcinoma Locally Advanced Bladder Urothelial Carcinoma Locally Advanced Lung Non-Small Cell Carcinoma Locally Advanced Renal Pelvis Carcinoma Locally Advanced Renal Pelvis Urothelial Carcinoma Locally Advanced Ureter Urothelial Carcinoma Locally Advanced Urethral Urothelial Carcinoma Malignant Solid Neoplasm Metastatic Bladder Carcinoma Metastatic Bladder Urothelial Carcinoma

Start date: 2021-09-23
Primary completion: 2027-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.